| Title |
Phase II study of Cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortium
|
|---|---|
| Published in |
Investigational New Drugs, November 2010
|
| DOI | 10.1007/s10637-010-9573-5 |
| Pubmed ID | |
| Authors |
Ajjai Alva, Susan Slovin, Stephanie Daignault, Michael Carducci, Robert DiPaola, Ken Pienta, David Agus, Kathleen Cooney, Alice Chen, David C. Smith, Maha Hussain |
Mendeley readers
The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 59 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 13 | 22% |
| Researcher | 8 | 14% |
| Student > Bachelor | 7 | 12% |
| Student > Doctoral Student | 5 | 8% |
| Professor > Associate Professor | 5 | 8% |
| Other | 12 | 20% |
| Unknown | 9 | 15% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 22 | 37% |
| Biochemistry, Genetics and Molecular Biology | 8 | 14% |
| Agricultural and Biological Sciences | 7 | 12% |
| Chemistry | 2 | 3% |
| Mathematics | 1 | 2% |
| Other | 5 | 8% |
| Unknown | 14 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 January 2023.
All research outputs
#7,720,531
of 23,477,147 outputs
Outputs from Investigational New Drugs
#341
of 1,193 outputs
Outputs of similar age
#36,672
of 101,966 outputs
Outputs of similar age from Investigational New Drugs
#6
of 26 outputs
Altmetric has tracked 23,477,147 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,193 research outputs from this source. They receive a mean Attention Score of 4.8. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 101,966 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.